Jones Financial Companies’s Nephros NEPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$90 Hold
31
﹤0.01% 4643
2025
Q4
$151 Hold
31
﹤0.01% 4290
2025
Q3
$138 Hold
31
﹤0.01% 4145
2025
Q2
$120 Hold
31
﹤0.01% 3943
2025
Q1
$52 Buy
+31
New +$49 ﹤0.01% 3653

Other funds holding NEPH

Jones Financial Companies's NEPH Position: Q1 2026 in Review

Jones Financial Companies held its Nephros (NEPH) position steady in Q1 2026 at 31 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #4643.

Jones Financial Companies first reported a position in NEPH in Q1 2025 and has held it in 5 quarters since. The position peaked at $151 in Q4 2025. 27 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

  • Jones Financial Companies held 31 shares of Nephros worth $90 as of Q1 2026.
  • Jones Financial Companies left its Nephros share count unchanged in Q1 2026.
  • Nephros made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4643 holding.
  • Jones Financial Companies first reported a position in Nephros in Q1 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Nephros position peaked at $151 in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.